iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
A stock price target is an analyst’s estimate of what a share may be worth, based on financial forecasts and a valuation method. It is not a promise that the stock will reach that price. For health insurers, forecasts can depend in part on medical costs, the mix of businesses the insurer operates, and how an analyst values its expected earnings or cash flows.
What a price target tells you
An analyst builds a forecast, applies a valuation method, and estimates a value per share. The result depends on assumptions about the company’s future performance and the market value investors may assign to it. Two analysts can therefore reach different targets for the same stock without making a calculation error: they may forecast different results, choose different valuation methods, or make different assumptions about growth and risk.
A target is meaningful only alongside its assumptions and time horizon. There is no single time horizon that all analysts use, so check the report’s stated period and publication date rather than assuming that every target refers to the same window.
How analysts turn forecasts into a target
Price-to-earnings approach
With a price-to-earnings (P/E) approach, an analyst forecasts earnings per share and applies a P/E multiple. The multiple reflects judgments about factors such as expected growth, risk, business quality, and the valuations of comparable companies. CMS defines P/E as share price divided by annual earnings per share and describes it as a relative comparison tool for managed-care companies. Its comparison covered 1995–2002, so it is historical context—not a current benchmark for valuing an insurer today. CMS managed-care valuation report.
#1 Best Overall
Discounted cash flow approach
A discounted cash flow (DCF) analysis estimates future cash flows and converts them into present value using a discount rate. Analysts also have to make assumptions about cash flows beyond the explicit forecast period, often represented by a terminal value, and account for debt when moving from business value to equity value per share. A 2018 transaction filing describing a Cigna DCF analysis illustrates these inputs; its figures are historical transaction assumptions, not current inputs for a health-insurer target. Cigna transaction filing.
Other methods and combinations
Analyst reports may use more than one method. A May 21, 2025 Jefferies report about CMS Info Systems—not a health insurer—describes methods including DCF, earnings, cash-flow and EBITDA multiples, peer comparisons, sum-of-the-parts, net asset value, dividends, and return on equity. It illustrates that methodology varies by company and report; it does not establish which method a particular health-insurer analyst uses. Jefferies report on CMS Info Systems.
Rank #2
Why medical loss ratio matters for health insurers
The medical loss ratio (MLR) measures the share of premium revenue spent on clinical services and quality improvement. The Centers for Medicare & Medicaid Services (CMS) says federal rules generally require insurers to spend at least 80% or 85% of premium dollars on medical care, depending on the applicable market, and require rebates when an issuer fails to meet the applicable standard. CMS Medical Loss Ratio information.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →MLR can inform an analyst’s view of an insurer’s costs and earnings, but a change in MLR does not have a universal, one-for-one effect on forecast earnings. The result depends on company-specific factors, including the business mix and the relevant markets. S&P Global identifies MLR as a key health-insurer performance indicator because it tracks the share of premium dollars used for medical care and quality improvement versus other costs. S&P Global on health-insurance KPIs.
MLR figures also need context. The National Association of Insurance Commissioners (NAIC) says the calculation is based on annual aggregate financial allocations by market and state. A ratio for one market or state should not automatically be treated as representative of a diversified insurer’s entire business. NAIC reports that 2023 rebates, paid in 2024, totaled $947 million for about 6.1 million families—an average of $156 per family. Those are the latest figures stated on the NAIC page accessed for this article, not a forecast or a measure of any one insurer’s results. NAIC explanation of health insurance and MLR.
How to compare two targets
Before treating one target as more credible than another, compare the underlying assumptions—not just the share prices.
- Forecast period and estimates: Check which period each analyst forecasts and the earnings or cash-flow estimates used.
- Valuation method: Identify whether the target uses P/E, DCF, another method, or a combination.
- Multiple and peers: For a relative valuation, examine the selected multiple, comparison group, and assumptions about growth and risk.
- DCF inputs: Compare projected cash flows, the discount rate, terminal value, and how debt is treated.
- Insurer operating assumptions: Look for explanations of claims experience, MLR, and business mix, and note which markets or states the operating figures cover.
- Report date and horizon: Targets and their inputs can change; use the publication date and the analyst’s stated time horizon when interpreting them.
A higher target may reflect higher forecast earnings, a higher valuation multiple, or different risk assumptions. Without the actual reports and a specific insurer’s forecasts, the difference cannot be attributed to one cause.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →What a target does not establish
A price target is a model-based estimate, not a guaranteed future price or a complete investment case. The methods and health-insurer measures described here explain how analysts can form a valuation, but they do not establish a current target, consensus price, or stock-specific valuation for any particular insurer.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
